Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | 192,260 | reported | 03 Feb 2026 | tx 53+1,934,780−457,222 |
| Anika Therapeutics, Inc. | 3,000 | reported | 08 Jul 2021 | tx 12+74,774−3,542 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 341,900 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 97,700 | 0.00 USD | deriv |
| 03 Feb 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 20,875 | — | |
| 03 Feb 2026 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 5,937 | 3.47 USD | |
| 03 Feb 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 20,875 | 0.00 USD | deriv |
| 01 Feb 2025 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 15,980 | 2.48 USD | |
| 02 Jan 2026 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 6,171 | 2.88 USD | |
| 31 Dec 2025 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 33,994 | 3.01 USD | |
| 31 Dec 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 73,750 | — | |
| 02 Jan 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 18,150 | — | |
| 02 Jan 2026 | EXERCISE | Aclaris Therapeutics, Inc. | 18,150 | 0.00 USD | deriv |
| 31 Dec 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 73,750 | 0.00 USD | deriv |
| 01 Feb 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 14,750 | — | |
| 01 Feb 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 7,500 | — | |
| 01 Feb 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 11,250 | — | |
| 01 Feb 2025 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 15,447 | 2.48 USD | |
| 01 Feb 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 01 Feb 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 14,750 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 292,300 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Aclaris Therapeutics, Inc. | 83,500 | 0.00 USD | deriv |
| 01 Feb 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 11,250 | 0.00 USD | deriv |
| 31 Dec 2024 | EXERCISE | Aclaris Therapeutics, Inc. | 73,750 | — | |
| 02 Jan 2025 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 8,575 | 2.48 USD | |
| 02 Jan 2025 | EXERCISE | Aclaris Therapeutics, Inc. | 18,150 | — | |
| 31 Dec 2024 | TAX_WITHHOLDING | Aclaris Therapeutics, Inc. | 32,089 | 2.48 USD |